Anti-CD19 CAR NK Cell Therapy for R/R Non-Hodgkin Lymphoma.
Clinical trial NCT04639739 · UNKNOWN
Trial details
- NCT number
- NCT04639739
- Sponsor
- Xinqiao Hospital of Chongqing
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-17
- Primary completion
- 2021-12-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.